This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Catherine A. VandeVoort
Introduction
Catherine A. VandeVoort is a prominent inventor based in El Macero, California. She has made significant contributions to the field of reproductive medicine, particularly in the area of in vitro fertilization (IVF) and embryo transfer (ET). Her work focuses on enhancing the success rates of these procedures through innovative methods.
Latest Patents
Catherine A. VandeVoort holds a patent titled "Relaxin levels correlated to IVF/ET pregnancy success." This patent discloses a method for determining the probability of success in IVF or ET procedures. It involves measuring relaxin levels directly in the serum or indirectly by culturing granulosa lutein cells extracted from the patient. Additionally, the patent outlines a method to enhance the rate of successful pregnancies resulting from IVF/ET by administering relaxin or enhancing endogenous relaxin levels through modifications in conventional procedures.
Career Highlights
Catherine is affiliated with the University of California, where she conducts her research and develops her innovative methods. Her work has garnered attention for its potential to improve outcomes for individuals undergoing fertility treatments.
Collaborations
Catherine A. VandeVoort collaborates with Dennis R. Stewart, who is also involved in the field of reproductive medicine. Their partnership aims to advance research and develop new techniques that can benefit patients seeking fertility solutions.
Conclusion
Catherine A. VandeVoort's contributions to reproductive medicine through her innovative patent demonstrate her commitment to improving IVF and ET success rates. Her work continues to impact the field positively, offering hope to many individuals and couples.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
